Aflac (NYSE:AFL – Free Report) had its target price reduced by Morgan Stanley from $105.00 to $100.00 in a research report sent to investors on Thursday morning,Benzinga reports.

Morgan Stanley lowered the firm’s price target on Aflac (AFL) to $100 from $105 and keeps an Equal Weight rating on the shares. On average ...

Aflac (NYSE:AFL – Free Report) had its target price raised by Piper Sandler from $118.00 to $124.00 in a research report released on Wednesday morning,Benzinga reports. The firm currently has an ...

Morgan Stanley has hired senior dealmaker David Kostel as the vice chairman of its health-care investment banking group, ...

Backed by Morgan Stanley’s deep sponsor network and a well-covered 10.3% dividend yield, MSDL offers both high income and ...

The firm lays out how the S&P 500 could break out above its current trading range between 5,000 and 5,500.

Morgan Stanley's Q1 2025 results show a 17% revenue increase and higher EPS, surpassing market expectations despite credit ...

Morgan Stanley shares are extremely overvalued and face significant downside risk in 2025, assuming economic contraction and bearish market conditions on Wall Street prevail. Key technical ...

Citing current market conditions, Morgan Stanley (NYSE: MS) analysts have upgraded three financial stocks, specifically ...